Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 February 2024.Powered by Capital Market - Live News

Net profit of Bafna Pharmaceuticals rose 54.04% to Rs 2.48 crore in the quarter ended September 2023 as against Rs 1.61 crore during the previous quarter ended September 2022. Sales rose 85.25% to Rs 40.68 crore in the quarter ended September 2023 as against Rs 21.96 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales40.6821.96 85 OPM %9.8311.57 - PBDT3.722.73 36 PBT2.481.61 54 NP2.481.61 54 Powered by Capital Market - Live News

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 November 2023.Powered by Capital Market - Live News

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 22 September 2023.Powered by Capital Market - Live News

Net profit of Bafna Pharmaceuticals rose 366.91% to Rs 6.35 crore in the quarter ended June 2023 as against Rs 1.36 crore during the previous quarter ended June 2022. Sales rose 147.79% to Rs 41.95 crore in the quarter ended June 2023 as against Rs 16.93 crore during the previous quarter ended June 2022. ParticularsQuarter Ended�Jun. 2023Jun. 2022% Var. Sales41.9516.93 148 OPM %14.999.81 - PBDT7.562.65 185 PBT6.351.36 367 NP6.351.36 367 Powered by Capital Market - Live News